Glomerulonephritis Clinical Trial
Official title:
Treatment of Early Immunoglobulin A Nephropathy by ACE Inhibitor - a Randomized Controlled Trial
To evaluate the efficacy of the ACE inhibitor ramipril in the treatment of early IgA nephropathy.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00001457 -
Lamivudine for Chronic Hepatitis B
|
Phase 2 | |
| Recruiting |
NCT05505955 -
Study of HRS-5965 in Healthy Subjects and Subjects With Renal Insufficiency
|
Phase 1 | |
| Recruiting |
NCT01240564 -
The Nephrotic Syndrome Study Network (NEPTUNE)
|
N/A | |
| Active, not recruiting |
NCT05174221 -
A Study of Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background Therapy
|
Phase 1 | |
| Completed |
NCT00426348 -
A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy
|
Phase 4 | |
| Recruiting |
NCT04662723 -
Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.
|
Phase 4 | |
| Completed |
NCT02700516 -
Recurrent Glomerulonephritis After Renal Transplantation
|
N/A | |
| Recruiting |
NCT00862693 -
Calcitriol in the Treatment of Immunoglobulin A Nephropathy
|
Phase 4 | |
| Completed |
NCT00983034 -
The Effects of Helicobacter Pylori Eradication on Proteinuria in Patients With Membranous Nephropathy
|
N/A | |
| Completed |
NCT00004990 -
Once-A-Month Steroid Treatment for Patients With Focal Segmental Glomerulosclerosis
|
Phase 2 | |
| Recruiting |
NCT04846010 -
Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2
|
Phase 1/Phase 2 | |
| Terminated |
NCT04387448 -
A Study of TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease
|
Phase 2 | |
| Terminated |
NCT04950114 -
An Open-Label, Long-term Study of GFB-887 in Patients With Glomerular Kidney Diseases
|
Phase 2 | |
| Terminated |
NCT02523768 -
Prevention in Recipients With Primary IgA Nephropathy of Recurrence After Kidney Transplantation: ATG-F Versus Basiliximab as Induction Immunosuppressive Treatment
|
Phase 4 | |
| Completed |
NCT00106561 -
Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the Kidney
|
Phase 2/Phase 3 | |
| Completed |
NCT04733040 -
Efficacy, Safety and PK/PD of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN) (NewPLACE)
|
Phase 2 | |
| Completed |
NCT00001676 -
Cyclophosphamide and Fludarabine to Treat Lupus Nephritis
|
Phase 1 | |
| Recruiting |
NCT02063100 -
Efficacy and Safety of Shenyankangfu Tablets for Primary Glomerulonephritis
|
Phase 4 | |
| Completed |
NCT01093157 -
A Dose Escalation Study of Long-acting ACTH Gel in Membranous Nephropathy
|
Phase 1/Phase 2 | |
| Completed |
NCT05283057 -
Empagliflozin in Patients With Glomerulonephritis
|
Phase 3 |